Uterine Leiomyomas as a Risk Factor for Infertility

Scott Cordts, MD
Ryan Luce, MD
Rebeca Nieves, MD

American Family Physician. 2026;113(4):388.

Author disclosure: No relevant financial relationships.

CLINICAL QUESTION

Are uterine leiomyomas a risk factor for infertility?

EVIDENCE-BASED ANSWER

Patients with more than one untreated leiomyoma may have decreased fertility as measured by pregnancy and live birth rates. (Strength of Recommendation: B, meta-analysis of randomized controlled trials and cohort studies.) Patients with a single leiomyoma smaller than 5 cm may have a lower pregnancy rate than those without leiomyomas. The specific location of leiomyomas (ie, subserosal, submucosal, intramural, simultaneous submucosal and intramural) may be associated with lower birth rates.

EVIDENCE SUMMARY

A 2024 systematic review and meta-analysis of 13 mostly prospective and retrospective studies (N = 4,788) examined pregnancy and birth rates in patients with leiomyomas vs those without leiomyomas. Mean patient age was 33 years. Patients were included if they had intramural leiomyomas (most were smaller than 8 cm) and were undergoing assisted reproductive technology or attempting conception. Patients with leiomyomas smaller than 2 to 3 cm and patients with leiomyomas larger than 2 to 3 cm were compared with those who did not have leiomyomas in terms of the clinical pregnancy rate. Primary outcomes were the rates of clinical pregnancy and live birth.1

For patients with more than one leiomyoma of any size, the pregnancy rate was significantly lower vs that in patients without any leiomyoma (four studies; n = 1,178; odds ratio [OR] = 0.62; 95% CI, 0.44–0.86; I2 = 24%). Stratified by size, compared with those without leiomyoma, patients with a leiomyoma smaller than 3 cm had a significantly lower pregnancy rate (three studies; n = 697; OR = 0.53; 95% CI, 0.38–0.76; I2 = 0%), as did those with a leiomyoma smaller than 5 cm (three studies; n = 1,598; OR = 0.75; 95% CI, 0.58–0.96; I2 = 0%).

The pregnancy rate was significantly lower in patients with leiomyomas between 3 and 6 cm than in those without leiomyomas (three studies; n = 743; OR = 0.43; 95% CI, 0.29–0.63; I2 = 0%). For patients with leiomyomas larger than 5 cm, the reduction was not significant (three studies; n = 615; OR = 0.71; 95% CI, 0.32–1.58; I2 = 57%). Patients with more than one leiomyoma of any size had a lower live birth rate vs those without (three studies; n = 868; OR = 0.53; 95% CI, 0.36–0.88; I2 = 41%). Limitations included lack of age or control for body mass index in some studies. Also, most data were retrospective.

A 2021 cohort study (N = 931) examined the relationship between location and size of leiomyomas and fertility. The study compared patients with submucosal, intramural, and simultaneous submucosal and intramural fibroids with those who had subserosal fibroids on pathologic examination after hysterectomy within a single institution during a 5-year period.2

Mean patient age was 47 years, and mean body mass index was 26.9 kg/m2. Patients with other possible causes of infertility were excluded. Primary outcomes were rates of birth, preterm birth, and early pregnancy loss. Compared with subserosal fibroids, submucosal fibroids (relative risk [RR] = 2.58; 95% CI, 1.03–6.47), intramural fibroids (RR = 1.18; 95% CI, 1.02–1.35), and simultaneous submucosal and intramural fibroids (RR = 1.36; 95% CI, 1.05–1.77) were associated with lower birth rates.

SCOTT CORDTS, MD, FAAFP; RYAN LUCE, MD; and REBECA NIEVES, MD, Deaconess Family Medicine Residency, Evansville, Indiana

Address correspondence to Scott Cordts, MD, FAAFP, at scott.cordts@deaconess.com.

Author disclosure: No relevant financial relationships.

  1. 1.Pritts TL, Ogden M, Parker W, et al. Intramural leiomyomas and fertility: a systematic review and meta-analysis. Obstet Gynecol. 2024;144(2):171-179.
  2. 2.Roşu G-A, Ionescu CA, Călin FD, et al. Prognostic value of the location of submucosal uterine leiomyomas in infertility. Exp Ther Med. 2021;22(6):1482.

Help Desk Answers provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email: questions@fpin.org.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN’s Help Desk Answers published in AFP is available at https://www.aafp.org/afp/hda.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.